Target Price | $76.20 |
Price | $72.45 |
Potential | 5.18% |
Number of Estimates | 23 |
23 Analysts have issued a price target Coca-Cola 2026 . The average Coca-Cola target price is $76.20. This is 5.18% higher than the current stock price. The highest price target is $85.00 17.32% , the lowest is $59.60 17.74% . | |
A rating was issued by 29 analysts: 22 Analysts recommend Coca-Cola to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Coca-Cola stock has an average upside potential 2026 of 5.18% . Most analysts recommend the Coca-Cola stock at Purchase. |
18 Analysts have issued a sales forecast Coca-Cola 2025 . The average Coca-Cola sales estimate is $48.0b . This is 2.66% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $49.0b 4.69% , the lowest is $47.5b 1.52% .
This results in the following potential growth metrics:
2024 | $46.8b | 2.04% |
---|---|---|
2025 | $48.0b | 2.66% |
2026 | $50.5b | 5.14% |
2027 | $53.4b | 5.80% |
2028 | $55.0b | 2.96% |
14 Analysts have issued an Coca-Cola EBITDA forecast 2025. The average Coca-Cola EBITDA estimate is $16.2b . This is 46.96% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $16.9b 52.99% , the lowest is $15.8b 43.42% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $10.9b | 13.26% |
---|---|---|
2025 | $16.2b | 48.34% |
2026 | $17.4b | 7.18% |
2027 | $18.9b | 8.86% |
2028 | $20.0b | 5.83% |
2024 | 23.34% | 15.00% |
---|---|---|
2025 | 33.72% | 44.50% |
2026 | 34.37% | 1.93% |
2027 | 35.36% | 2.88% |
2028 | 36.35% | 2.80% |
9 Coca-Cola Analysts have issued a net profit forecast 2025. The average Coca-Cola net profit estimate is $12.5b . This is 18.04% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $12.8b 20.73% , the lowest is $11.4b 7.72% .
This results in the following potential growth metrics and future Net Margins:
2024 | $10.6b | 0.40% |
---|---|---|
2025 | $12.5b | 18.04% |
2026 | $13.7b | 10.01% |
2027 | $14.9b | 8.14% |
2028 | $16.1b | 8.38% |
2024 | 22.63% | 2.40% |
---|---|---|
2025 | 26.02% | 14.98% |
2026 | 27.22% | 4.61% |
2027 | 27.83% | 2.24% |
2028 | 29.29% | 5.25% |
9 Analysts have issued a Coca-Cola forecast for earnings per share. The average Coca-Cola EPS is $2.90 . This is 17.89% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.97 20.73% , the lowest is $2.65 7.72% .
This results in the following potential growth metrics and future valuations:
2024 | $2.46 | 0.40% |
---|---|---|
2025 | $2.90 | 17.89% |
2026 | $3.19 | 10.00% |
2027 | $3.45 | 8.15% |
2028 | $3.74 | 8.41% |
Current | 29.44 | 24.69% |
---|---|---|
2025 | 24.95 | 15.25% |
2026 | 22.68 | 9.10% |
2027 | 20.97 | 7.54% |
2028 | 19.35 | 7.73% |
Based on analysts' sales estimates for 2025, the Coca-Cola stock is valued at an EV/Sales of 7.17 and an P/S ratio of 6.49 .
This results in the following potential growth metrics and future valuations:
Current | 7.36 | 19.48% |
---|---|---|
2025 | 7.17 | 2.60% |
2026 | 6.82 | 4.89% |
2027 | 6.44 | 5.48% |
2028 | 6.26 | 2.87% |
Current | 6.67 | 21.71% |
---|---|---|
2025 | 6.49 | 2.59% |
2026 | 6.18 | 4.89% |
2027 | 5.84 | 5.48% |
2028 | 5.67 | 2.87% |
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Feb 28 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 13 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Feb 12 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Feb 12 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Feb 12 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Feb 12 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Feb 06 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Feb 28 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 13 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Feb 12 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Feb 12 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Feb 12 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Feb 12 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Feb 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.